Aehr Test Systems Sees Unusually Large Options Volume (NASDAQ:AEHR)

Aehr Test Systems (NASDAQ:AEHR) saw some unusual options trading on Monday. Traders acquired 11,818 call options on the company. This represents an increase of 198% compared to the typical daily volume of 3,972 call options.

Aehr Test Systems Stock Performance

Shares of AEHR stock opened at $52.16 on Tuesday. The stock’s 50-day moving average is $34.77 and its two-hundred day moving average is $28.54. The firm has a market cap of $1.60 billion, a price-to-earnings ratio of -173.86 and a beta of 2.28. Aehr Test Systems has a 1 year low of $6.58 and a 1 year high of $52.62.

Aehr Test Systems (NASDAQ:AEHR) last released its quarterly earnings results on Thursday, January 8th. The semiconductor company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.04. Aehr Test Systems had a negative return on equity of 4.57% and a negative net margin of 16.63%.The firm had revenue of $9.88 million for the quarter, compared to analyst estimates of $11.45 million. As a group, research analysts predict that Aehr Test Systems will post 0.1 EPS for the current year.

Analyst Ratings Changes

AEHR has been the topic of several research reports. Zacks Research raised Aehr Test Systems from a “strong sell” rating to a “hold” rating in a report on Monday, December 8th. William Blair raised Aehr Test Systems from a “market perform” rating to an “outperform” rating in a report on Monday, March 2nd. Craig Hallum reaffirmed a “hold” rating on shares of Aehr Test Systems in a report on Friday, January 9th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Aehr Test Systems in a report on Wednesday, January 21st. Finally, Lake Street Capital initiated coverage on Aehr Test Systems in a report on Wednesday, December 17th. They set a “buy” rating on the stock. Two investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $21.00.

Insiders Place Their Bets

In other Aehr Test Systems news, Director Rhea J. Posedel sold 13,998 shares of the firm’s stock in a transaction on Friday, February 13th. The stock was sold at an average price of $30.02, for a total value of $420,219.96. Following the sale, the director directly owned 456,979 shares in the company, valued at $13,718,509.58. This trade represents a 2.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Laura Oliphant sold 4,546 shares of the firm’s stock in a transaction on Thursday, January 22nd. The shares were sold at an average price of $31.40, for a total value of $142,744.40. Following the completion of the sale, the director owned 18,432 shares in the company, valued at approximately $578,764.80. This represents a 19.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 6.80% of the stock is owned by company insiders.

Hedge Funds Weigh In On Aehr Test Systems

A number of hedge funds and other institutional investors have recently made changes to their positions in AEHR. Royal Bank of Canada grew its holdings in shares of Aehr Test Systems by 262.7% during the first quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock worth $365,000 after buying an additional 36,364 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Aehr Test Systems by 8.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock worth $126,000 after buying an additional 1,344 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Aehr Test Systems by 7.9% during the second quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock worth $201,000 after buying an additional 1,145 shares during the last quarter. Legal & General Group Plc grew its holdings in shares of Aehr Test Systems by 110.8% during the second quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company’s stock worth $89,000 after buying an additional 3,617 shares during the last quarter. Finally, Rhumbline Advisers grew its holdings in shares of Aehr Test Systems by 3.1% during the second quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock worth $536,000 after buying an additional 1,254 shares during the last quarter. Hedge funds and other institutional investors own 69.69% of the company’s stock.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.